¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"modification gene"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
allotropic modification
µ¿¼Òüº¯Çü
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification
º¯Çü, º¯È, º¯°æ, ¼ö½Ä, ¼öÁ¤
phenotypic modification
Ç¥ÇöÇüº¯È
autosomal gene
º¸Åë¿°»öüÀ¯ÀüÀÚ
additive gene
»ó°¡À¯ÀüÀÚ
allelic gene
´ë¸³À¯ÀüÀÚ
complementary gene
º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
control gene
Á¦¾îÀ¯ÀüÀÚ
cooperating gene
Çùµ¿À¯ÀüÀÚ
catabolite (gene) activator protein
ºÐÇØ´ë»ç»ê¹°(À¯ÀüÀÚ)Ȱ¼º´Ü¹éÁú
calcitonin gene-related peptide
Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
candidate gene
Èĺ¸À¯ÀüÀÚ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
13
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
modification
º¯È, ¼ö½Ä
behavioral modification
Çൿ¼öÁ¤
gene
À¯ÀüÀÚ
allelic gene
´ë¸³À¯ÀüÀÚ
regulator gene
Á¶ÀýÀ¯ÀüÀÚ
structural gene
±¸Á¶À¯ÀüÀÚ
suicide gene
ÀÚ»ìÀ¯ÀüÀÚ
supressor gene
¾ïÁ¦À¯ÀüÀÚ
tumor suppressor gene
Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
gene transfer
À¯ÀüÀÚÀü´Þ
gene translocation
À¯ÀüÀÚÀüÀ§
gene transfection
1.À¯ÀüÀÚÀü´Þ°¨¿°, 2.À¯ÀüÀÚÇÙ³»ÁÖÀÔ
gene therapy
À¯ÀüÀÚ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification
º¯È, ¼ö½Ä
phenotypic modification
Ç¥ÇöÇüº¯È
additive gene
»ó°¡À¯ÀüÀÚ
allelic gene
´ë¸³À¯ÀüÀÚ
autosomal gene
º¸Åë¿°»öüÀ¯ÀüÀÚ
gene amplification
À¯ÀüÀÚÁõÆø
gene analysis
À¯ÀüÀںм®
complementary gene
º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
control gene
Á¦¾îÀ¯ÀüÀÚ
cooperating gene
Çùµ¿À¯ÀüÀÚ
gene cloning
À¯ÀüÀÚŬ·Î´×
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü(ÔÒáÈô÷ܨû¡).
antigen modification
Ç׿øº¯Çü.
phenotypic modification
Ç¥ÇöÇü ¼ö½Ä, Ç¥ÇöÇü º¯È
C-fos gene
¾¾-Æ÷½ºÀ¯ÀüÀÚ(ë¶îîí)
C-jun gene
¾¾-ÁØ À¯ÀüÀÚ(ë¶îîí)
DNA mediated gene transfer
DNA ¸Å°³¼ºÀ¯ÀüÀÚÀüÀÌ
DP gene
DPÀ¯ÀüÀÚ
DQ gene
DQÀ¯ÀüÀÚ
DR gene
DRÀ¯ÀüÀÚ
Gag gene
gag À¯Àü(ÀÎ)ÀÚ
Gene therapy
À¯ÀüÀÚÄ¡·á(ö½Öû)
Hfr mediated gene transfer
°íºóµµÀçÁ¶ÇÕ¼¼Æ÷¸Å°³ À¯ÀüÀÚÀüÀÌ
Onc gene
Onc À¯ÀüÀÚ
Src gene
Src À¯Àü(ÀÎ)ÀÚ
T cell receptor gene
T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü(ÔÒáÈô÷ܨû¡).
antigen modification
Ç׿øº¯Çü.
behavior modification technique
Çൿ(ÇàÅÂ)¼öÁ¤±â¹ý
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification of karyotype
ÇÙÇüº¯ÀÌ
modification, behavioral
phenotypic modification
Ç¥ÇöÇü ¼ö½Ä, Ç¥ÇöÇü º¯È
additive gene
»ó°¡À¯ÀüÀÚ(ßÓÊ¥ë¶îîí).
allelic gene
´ë¸³À¯ÀüÀÚ
aniridia,pax-6 gene
PAX-6 À¯ÀüÀÚ(¡ë¶îîí)
apc gene
APC À¯ÀüÀÚ(¡ë¶îîí)
atk gene
atk À¯ÀüÀÚ(¡ë¶îîí)
autosomal gene
º¸Åë¿°»öüÀ¯ÀüÀÚ
bcg gene
bcg À¯ÀüÀÚ(¡ë¶îîí)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½